Document is current
Any future updates will be listed below
-
Authors
Marquardt, Viktoria
Theruvath, Johanna
Pauck, David
Picard, Daniel
Qin, Nan
Blümel, Lena
Maue, Mara
Bartl, Jasmin
Ahmadov, Ulvi
Langini, Maike
Meyer, Frauke-Dorothee
Cole, Allison
Cruz-Cruz, Joselyn
Graef, Claus M
Wölfl, Matthias
Milde, Till
Witt, Olaf
Erdreich-Epstein, Anat
Leprivier, Gabriel
Kahlert, Ulf
Stefanski, Anja
Stühler, Kai
Keir, Stephen T
Bigner, Darell D
Hauer, Julia
Beez, Thomas
Knobbe-Thomsen, Christiane B
Fischer, Ute
Felsberg, Jörg
Hansen, Finn K
Vibhakar, Rajeev
Venkatraman, Sujatha
Cheshier, Samuel H
Reifenberger, Guido
Borkhardt, Arndt
Kurz, Thomas
Remke, Marc
Mitra, Siddhartha https://orcid.org/0000-0002-1829-7856
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02212574 at ClinicalTrials.govnct01878617 at ClinicalTrials.govDocuments that mention this clinical trial
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation
https://doi.org/10.1136/jitc-2022-005871
Documents that mention this clinical trial
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation
https://doi.org/10.1136/jitc-2022-005871
-
Funding
Funding for this research was provided by:
Comprehensive Cancer Center Düsseldorf (N/A)
German Academic Scholarship Foundation (N/A)
National Cancer Institute (P30-CA046934)
Hempel Fonden (N/A)
Plachy-Rubin Foundation (N/A)
V Foundation for Cancer Research (V2021-013)
Wegener Foundation (N/A)
Bundesministerium für Bildung und Forschung (01ZX1401B)
Bundesministerium für Bildung und Forschung (03VP0731)
Deutschen Konsortium für Translationale Krebsforschung (N/A)
Morgan Adams Foundation (2380102)
Cancer League of Colorado (25B0712)
The Broncos Foundation (N/A)
Deutsche Krebshilfe (110663)
Deutsche Krebshilfe (111537)
Deutsche Krebshilfe (70112951)
Deutsche Krebshilfe (P-91650709)
American Cancer Society-IRG (16-184-56)
Andrew McDonough B+ Foundation (612617)
- License Information
